Loading...
XSAU
4013
Market cap24bUSD
Nov 12, Last price  
264.00SAR
Name

Dr Sulaiman Al-Habib Medical Services Group Co

Chart & Performance

D1W1MN
XSAU:4013 chart
P/E
39.91
P/S
8.25
EPS
6.62
Div Yield, %
1.77%
Shrs. gr., 5y
Rev. gr., 5y
17.43%
Revenues
11.20b
+17.79%
5,122,630,9734,868,000,8344,379,026,0234,587,633,0455,016,280,1055,861,604,6367,250,472,1908,310,738,5149,508,438,76811,200,434,264
Net income
2.32b
+13.16%
1,328,868,0361,009,937,185656,166,762801,307,353870,231,1711,055,482,3201,376,615,1971,650,750,0472,046,013,9222,315,290,800
CFO
2.97b
-6.97%
922,111,786899,872,3971,083,111,0461,434,596,5561,059,091,8062,178,002,2212,182,793,1272,843,681,2353,192,979,0672,970,397,894
Dividend
Aug 01, 20241.17 SAR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Dr. Sulaiman Al Habib Medical Services Group Company establishes, manages, and operates hospitals, general and specialized medical complexes, day surgery centers, and pharmaceutical facilities in Saudi Arabia. The company operates maternity, and orthopedics and spinal surgeries hospitals. It also operates dermatology, plastic surgery, ophthalmology, obesity treatment, and fertility centers, as well as pharmacies. In addition, the company provides home medical care, specialized medical laboratories, technology, information systems, and facility maintenance services, as well as medical equipment maintenance and telemedicine services. Dr. Sulaiman Al Habib Medical Services Group Company was founded in 1993 and is headquartered in Riyadh, Saudi Arabia.
IPO date
Feb 26, 2020
Employees
Domiciled in
SA
Incorporated in
SA

Valuation

Title
SAR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT